Peter H. van Rooij

Radiotherapy for <scp>T</scp>1‐2<scp>N</scp>0 glottic cancer: a multivariate analysis of predictive factors for the long‐term outcome in 1050 patients and a prospective assessment of quality of life and voice handicap index in a subset of 233 patients

Abrahim Al‐Mamgani, Peter H. van Rooij, D. Woutersen et al. · Clinical Otolaryngology · 2013 · 82 citations

Radiotherapy for T1a glottic cancer: the influence of smoking cessation and fractionation schedule of radiotherapy

Abrahim Al‐Mamgani, Peter H. van Rooij, Robert Mehilal et al. · European Archives of Oto-Rhino-Laryngology · 2013 · 55 citations

Adaptive Radiotherapy, Health Sciences, Radiation Therapy +9

The Role of Chemo-Radiotherapy in the Management of Locally Advanced Carcinoma of the Vulva

Lisa Tans, Anca C. Ansink, Peter H. van Rooij et al. · American Journal of Clinical Oncology · 2010 · 50 citations

Toxicity, quality of life, and functional outcomes of 176 hypopharyngeal cancer patients treated by (Chemo)radiation: The impact of treatment modality and radiation technique

Abrahim Al‐Mamgani, Robert Mehilal, Peter H. van Rooij et al. · The Laryngoscope · 2012 · 48 citations

High-Dose-Rate Brachytherapy and External-Beam Radiotherapy for Hormone-Naïve Low- and Intermediate-Risk Prostate Cancer: A 7-Year Experience

Shafak Aluwini, Peter H. van Rooij, Wim J. Kirkels et al. · International Journal of Radiation Oncology*Biology*Physics · 2012 · 32 citations · Full text

Urology, Radiation Medicine, Radiation Therapy +7